AU3466799A - Use of l-glu-l-trp in the treatment of hiv infection - Google Patents

Use of l-glu-l-trp in the treatment of hiv infection Download PDF

Info

Publication number
AU3466799A
AU3466799A AU34667/99A AU3466799A AU3466799A AU 3466799 A AU3466799 A AU 3466799A AU 34667/99 A AU34667/99 A AU 34667/99A AU 3466799 A AU3466799 A AU 3466799A AU 3466799 A AU3466799 A AU 3466799A
Authority
AU
Australia
Prior art keywords
trp
xaa
glu
compound
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34667/99A
Other languages
English (en)
Inventor
Lawrence R Green
Nickolay V. Sinackevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTRAN Ltd
Original Assignee
CYTRAN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CYTRAN Ltd filed Critical CYTRAN Ltd
Publication of AU3466799A publication Critical patent/AU3466799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34667/99A 1998-04-03 1999-04-02 Use of l-glu-l-trp in the treatment of hiv infection Abandoned AU3466799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5509298A 1998-04-03 1998-04-03
US09055092 1998-04-03
PCT/US1999/007297 WO1999051256A2 (fr) 1998-04-03 1999-04-02 Utilisation de l-glu-l-trp pour le traitement d'une infection par vih

Publications (1)

Publication Number Publication Date
AU3466799A true AU3466799A (en) 1999-10-25

Family

ID=21995541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34667/99A Abandoned AU3466799A (en) 1998-04-03 1999-04-02 Use of l-glu-l-trp in the treatment of hiv infection

Country Status (4)

Country Link
EP (1) EP1067951A2 (fr)
AU (1) AU3466799A (fr)
CA (1) CA2326760A1 (fr)
WO (1) WO1999051256A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112752612A (zh) * 2018-07-30 2021-05-04 美卓矿物工业公司 包括变速驱动器和控制系统的回转破碎机

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417960C (fr) 2000-08-04 2012-07-10 Dmi Biosciences, Inc. Methode d'utilisation de dicetopiperazines et composition contenant ces substances
CN104095851A (zh) * 2003-05-15 2014-10-15 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
EP2300011A4 (fr) 2008-05-27 2012-06-20 Dmi Life Sciences Inc Procédés et composés thérapeutiques
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
PL2766029T3 (pl) 2011-10-10 2020-08-24 Ampio Pharmaceuticals, Inc. Leczenie choroby zwyrodnieniowej stawów
KR20140075772A (ko) 2011-10-10 2014-06-19 앰피오 파마슈티컬스 인코퍼레이티드 면역 내성을 증가시킨 이식 의료 장비, 및 그의 제조 및 이식 방법
CN103841974A (zh) 2011-10-28 2014-06-04 安皮奥制药股份有限公司 鼻炎的治疗
MX2015010937A (es) 2013-03-15 2015-10-29 Ampio Pharmaceuticals Inc Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas.
CA2958080A1 (fr) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Traitement de pathologies articulaires
EP3310375A4 (fr) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Utilisation de fractions d'albumine de sérum humain de bas poids moléculaire pour traiter les maladies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) * 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
IT1237474B (it) * 1989-10-05 1993-06-07 Polifarma Spa Composti tripeptidici e loro uso farmaceutico come immuno-modulatori
WO1994020063A2 (fr) * 1993-03-04 1994-09-15 Cytoven International N.V. Tryptophane pharmaceutique contenant des compositions dipeptidiques et modes d'utilisation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112752612A (zh) * 2018-07-30 2021-05-04 美卓矿物工业公司 包括变速驱动器和控制系统的回转破碎机

Also Published As

Publication number Publication date
CA2326760A1 (fr) 1999-10-14
WO1999051256A2 (fr) 1999-10-14
EP1067951A2 (fr) 2001-01-17
WO1999051256A3 (fr) 1999-12-09

Similar Documents

Publication Publication Date Title
ES2251196T3 (es) Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica.
ES2296792T3 (es) Composiciones farmaceuticas para cefalea, ,migraña, nauseas y emesis.
US6617310B2 (en) Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
WO2001074768A2 (fr) Inhibiteurs de serine proteases, notamment de la protease ns3 du virus de l'hepatite c
BRPI0410792B1 (pt) compostos de anfetamina resistentes à dependencia
JPH0150684B2 (fr)
KR20060102556A (ko) 과용 또는 남용을 예방하기 위한 제약 조성물
AU3466799A (en) Use of l-glu-l-trp in the treatment of hiv infection
CN1301158A (zh) 用于治疗人类获得性免疫缺陷病毒和其它病毒感染的组合物
AU2004233587A1 (en) Use of a topical medicament comprising Riluzole
JP3906716B2 (ja) 耐糖能異常用薬剤
WO2009115634A1 (fr) Combinaisons synergiques de 5'-méthylthioadénosine
ES2231814T3 (es) Efectos metabolicos de ciertos analogos de glutation.
JP2006511538A (ja) 非ヌクレオシド系逆転写酵素阻害剤（ｎｎｒｔｉ）とプロテアーゼ阻害剤などのシトクロムｐ４５０の阻害剤とを含む組み合わせの使用
JPH09503776A (ja) 医療に使用する化合物
KR0178762B1 (ko) 특정 인돌 유도체의 신규 의약적 용도 및 그를 함유하는 제약 조성물
JP4672257B2 (ja) エポチロンを含む組成物およびカルチノイド症候群の治療のためのそれらの使用
LV13462B (en) Tetrapeptide regulating blood glucose level in diabetes mellitus
US6649644B1 (en) Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor
JP6027335B2 (ja) 耐糖能異常用飲食品添加剤
JP2008297208A (ja) アンジオテンシンｉ変換酵素阻害剤
Maruyama et al. Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy
JP2000186040A (ja) 抗ｈｉｖ感染症剤
JP2006028194A (ja) 耐糖能異常用医薬組成物及び飲食品
RO116164B1 (ro) Metoda de inhibare a infectiei retrovirale

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted